Predictions of Systemic, Intracellular, and Lung Concentrations of Azithromycin with Different Dosing Regimens used in COVID‐19 Clinical Trials
Azithromycin, a broad‐spectrum macrolide antibiotic, is being investigated in patients with COVID‐19. A population pharmacokinetic model was implemented to predict lung, intracellular poly/mononuclear cell (PBM/PML), and alveolar macrophage (AM) concentrations using published data and compared again...
| Autor principal: | |
|---|---|
| Formato: | Other publications |
| Publicado: |
2020-06-08
|
| Materias: | |
| Acceso en línea: | https://doi.org/10.1002/psp4.12537 https://hdl.handle.net/20.500.12663/1775 |